# Recall of Mapakna LP 20 mg from Majorelle Laboratories

> Healthcare establishments are informed of a recall of Mapakna LP 20 mg, prolonged-release tablet, from Majorelle Laboratories. It is a national health safety measure.

**In brief**: Health event (severity: low) nationwide, first detected on 18 November 2026 at 00:00. Reported by 1 source (1 article), last updated on 18 November 2026 at 00:00.

- Category: Health
- Severity: Low
- Place: Nationwide
- First detected: 18 November 2026 at 00:00
- Updated: 18 November 2026 at 00:00
- Web page: https://acturadar.com/en/events/23760-recall-of-mapakna-lp-20-mg-from-majorelle-laboratories

## Sources (1 articles)

- [Mapakna LP 20 mg, comprimé à libération prolongée – Laboratoires Majorelle](https://ansm.sante.fr/informations-de-securite/mapakna-lp-20-mg-comprime-a-liberation-prolongee-laboratoires-majorelle) — ANSM, 18 November 2026 at 00:00

---

Cite as: Acturadar, “Recall of Mapakna LP 20 mg from Majorelle Laboratories”, https://acturadar.com/en/events/23760-recall-of-mapakna-lp-20-mg-from-majorelle-laboratories
Methodology: https://acturadar.com/en/methodology
